US EditionElon Musk's Neuralink says it has FDA approval for first human clinical study
- Elon Musk's brain-implant company, Neuralink, has received FDA approval to begin its first-in-human clinical study after initially facing rejection due to safety concerns.
- The implant aims to treat conditions such as paralysis and blindness through direct brain-computer interfacing.
- The approval represents an important first step for the company's technology and comes as U.S. Lawmakers raise concerns over animal testing and experimental procedures at Neuralink.
Insights by Ground AI
Does this summary seem wrong?
222 Articles
222 Articles
All
Left
46
Center
70
Right
47
Coverage Details
Total News Sources222
Leaning Left46Leaning Right47Center70Last UpdatedBias Distribution43% Center
Bias Distribution
- 43% of the sources are Center
43% Center
L 28%
C 43%
R 29%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
